Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 68Prostatic Neoplasms 44Leukemia, Myeloid, Acute 35Melanoma 34Lung Neoplasms 28Carcinoma, Non-Small-Cell Lung 28Pancreatic Neoplasms 26Myelodysplastic Syndromes 23Multiple Myeloma 23Colorectal Neoplasms 23Leukemia, Lymphocytic, Chronic, B-Cell 22Neoplasms 21Squamous Cell Carcinoma of Head and Neck 19Neoplasm Metastasis 19Lymphoma, Large B-Cell, Diffuse 19Rectal Neoplasms 16Lymphoma, Mantle-Cell 14Carcinoma, Renal Cell 14Triple Negative Breast Neoplasms 13Stomach Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Colonic Neoplasms 13Lymphoma, Follicular 12Uterine Cervical Neoplasms 11Ovarian Neoplasms 11Leukemia, Myelomonocytic, Chronic 11Head and Neck Neoplasms 11Esophageal Neoplasms 11Myeloproliferative Disorders 10Mouth Neoplasms 9

Interventions

Fluorodeoxyglucose F18 7Irinotecan 4Fluorouracil 4Cyclophosphamide 4Bevacizumab 4toripalimab 3pembrolizumab 3olaparib 3Radiosurgery 3Cisplatin 3Capecitabine 3vistusertib 2tislelizumab 2spartalizumab 2fludarabine 2atezolizumab 2apatinib 2Temozolomide 2Technetium 2Specimen Handling 2Sirolimus 2Radiotherapy 2Proton Therapy 2Paclitaxel 2Leucovorin 2Letrozole 2Hydroxychloroquine 2Everolimus 2Drug Therapy 2Docetaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Solid Tumor × Biopsy × Clear all
NCT00483457 2012-09-03

Effects of Epidermal Growth Factor Receptor Inhibitor Therapy in the Skin of Cancer Patients

Vanderbilt-Ingram Cancer Center

Completed
33 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡